Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Jardiance is EU approved for the treatment of heart failure with reduced ejection fraction – Boehringer + Eli Lilly

Written by | 30 Jun 2021

The European Commission has granted marketing authorization for Jardiance (empagliflozin) as a treatment for adults with symptomatic chronic heart failure with reduced ejection fraction (systolic heart failure), Boehringer… read more.

Gut to brain: Nerve cells detect what we eat

Written by | 20 Jun 2021

The gut and the brain communicate with each other in order to adapt satiety and blood sugar levels during food consumption. The vagus nerve is an important communicator… read more.

Liraglutide prevents accumulation of lipid linked to cardiac mortality

Written by | 14 Jun 2021

Researchers at the Karolinska Institutet, University of Oxford and University of Copenhagen have shown that elevated levels of lipids known as ceramides can be associated with a ten-fold… read more.

Testosterone therapy may reduce non-alcoholic fatty liver disease in obese

Written by | 12 Jun 2021

According to a new study, testosterone therapy may reduce non-alcoholic fatty liver disease in obese men with functional hypogonadism and type-2 diabetes. Testosterone therapy may help obese men… read more.

Fluvoxamine for early treatment of covid-19

Written by | 8 Jun 2021

Article by Christine Clark. Evidence from trials and real world experience shows that selective serotonin reuptake inhibitors (SSRIs) are effective in treating acute covid and preventing long-haul covid.

Data from smartwatches can help predict clinical blood test results

Written by | 30 May 2021

Long-term data gathered from wearables can quicky indicate illness and other abnormalities in a patient’s health. DURHAM, N.C. — Smartwatches and other wearable devices may be used to… read more.

Study links secondhand smoke during pregnancy to epigenetic changes in babies

Written by | 26 May 2021

Nearly a quarter of pregnant women say they’ve been around secondhand smoke — in their homes, at work, around a friend or relative — which, according to new… read more.

Four-month TB therapy proves as effective as 6-month standard regimen

Written by | 24 May 2021

Four months of multi-drug therapy that included rifapentine and moxifloxacin treated active tuberculosis (TB) as effectively as the standard six-month regimen in a multinational study, cutting treatment time… read more.

Home isolation and ivermectin-based treatment kits

Written by | 21 May 2021

Interview and article by Christine Clark. Dr Suryakant (Head of the Department of Respiratory Medicine at King George Medical University in Lucknow, India) explains how an ivermectin-based therapy… read more.

Semaglutide leads to significant weight loss in Type 2 diabetes patients

Written by | 17 May 2021

Article by Bruce Sylvester. Patients diagnosed with type 2 diabetes and treated with weekly semaglutide have achieved an average weight loss of almost 10kg, researchers reported on March… read more.

Researchers find enzyme that could unlock kidney treatment

Written by | 15 May 2021

Article written by Gary Finnegan. Chronic kidney disease affects approximately 700 million people worldwide with many going on to require dialysis. Now a new enzyme has been discovered… read more.

Diabetes study stumbles across undetected COVID-19 cases in children

Written by | 14 May 2021

Article written by Gary Finnegan. A study that screened children for early-stage type 1 diabetes has detected a rate of COVID-19 infection higher than the number of cases… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.